Molecular Templates, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Common Share (Tables)

Net Loss Per Common Share (Tables)

3 Months Ended

Mar. 31, 2015

Reconciliation of Numerator and Denominator

A reconciliation of the numerator and denominator used in the calculation is as follows (in thousands, except per share amounts):

	Three Months Ended March 31,
	2015			2014
Numerator:
Net loss - basic	$	(11,154	)	$	(7,109	)
Less: noncash income from change in fair value of common stock warrants		—			1,757

Net loss - diluted		(11,154	)		(8,866	)

Denominator:
Weighted average common shares outstanding		66,732			59,303
Dilutive effect of warrants		0			1,997

Weighted-average common shares outstanding and dilutive potential common shares — diluted		66,732			61,300

Net loss per share
Basic	$	(0.17	)	$	(0.12	)
Diluted	$	(0.17	)	$	(0.14	)

Warrants, Options and Purchase Rights Excluded from Computation of Diluted Net Loss Per Share

The following outstanding warrants, options and purchase rights under the Company’s 2004 Employee Stock Purchase Plan (“2004 Purchase Plan”) were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an antidilutive effect (in thousands):

	Three Months Ended March 31,
	2015		2014
Shares issuable upon exercise of warrants		12,146		4,288
Shares issuable upon exercise of stock options		9,993		6,656
Shares issuable related to the 2004 Purchase Plan		29		31